Walleye Capital LLC Protalix Bio Therapeutics, Inc. Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Mar 03, 2022	SELL	$0.81 - $1.33 $178,272 - $292,718	-220,089 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$1.31 - $1.87 $165,649 - $236,461	-126,450 Reduced 36.49%	220,089 $293,000
Q2 2021 Aug 16, 2021	BUY	$1.86 - $6.22 $644,562 - $2.16 Million	346,539 New	346,539 $662,000
Q3 2020 Nov 16, 2020	SELL	$3.37 - $3.93 $197,512 - $230,333	-58,609 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.19 - $4.5 $128,353 - $263,740	58,609 New	58,609 $222,000

3.58M

61.1K

36.2K

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $86.1M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.